PHN Share Price Performance
Recent PHN News & Updates
No updates
Pharmanutra S.p.A. Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
Sep 08, 2025
- Earnings per share (EPS)
- 1.73
- Gross Margin
- 51.00%
- Net Profit Margin
- 14.30%
- Debt/Equity Ratio
- 36.3%
Pharmanutra S.p.A. Competitors
About PHN
- Founded
- 2003
- Employees
- 118
- CEO
- WebsiteView website
Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, Europe, the Middle East, South America, Far East, and internationally. The company produces and distributes raw materials and active ingredients for the food, pharmaceutical, and dietary supplement industries. It also offers iron deficiency, inflammation, mineral and vitamin, muscle and joint, sports nutrition, ophthalmic, and night rest products; and medical instrumentation and software for body bioimpedance analysis. The company sells its products through sales representatives, wholesalers, pharmacies, para-pharmacies, agents, distributors, online sales, local partners, and tenders. Pharmanutra S.p.A. was founded in 2003 and is based in Pisa, Italy.
Italian Market Performance
- 7 Days: -2.1%
- 3 Months: 3.3%
- 1 Year: 22.3%
- Year to Date: 14.4%
Over the last 7 days, the market has dropped 2.1%, driven by a decline of 9.9% in the Consumer Discretionary sector. As for the longer term, the market has actually risen by 22% in the last year. Earnings are forecast to grow by 8.3% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading